Comparison between Accretion Nutraveda IPO and Harikanta Overseas IPO.
Accretion Nutraveda IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Harikanta Overseas IPO is a SME Bookbuilding proposed to list at BSE SME.
| Accretion Nutraveda IPO | Harikanta Overseas IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Interactive Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Aftertrade Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Nutraveda IPO is up to ₹23.53 Cr whereas the issue size of the Harikanta Overseas IPO is up to ₹23.07 Cr. The final issue price of Accretion Nutraveda IPO is ₹129.00 per share and of Harikanta Overseas IPO is ₹91.00 per share.
| Accretion Nutraveda IPO | Harikanta Overseas IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹122.00 per share | ₹86.00 per share |
| Issue Price (Upper) | ₹129.00 per share | ₹91.00 per share |
| Issue Price (Final) | ₹129.00 per share | ₹91.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1200 shares |
| Fresh Issue Size | 18,24,000 shares | 25,35,600 shares |
| Fresh Issue Size (Amount) | up to ₹23.53 Cr | up to ₹23.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 18,24,000 shares | 25,35,600 shares |
| Issue Size Total (Amount) | up to ₹23.53 Cr | up to ₹23.07 Cr |
Accretion Nutraveda IPO opens on Jan 28, 2026, while Harikanta Overseas IPO opens on May 20, 2026. The closing date of Accretion Nutraveda IPO and Harikanta Overseas IPO is Jan 30, 2026, and May 27, 2026, respectively.
| Accretion Nutraveda IPO | Harikanta Overseas IPO | |
|---|---|---|
| Anchor Bid Date | Jan 27, 2026 | |
| Issue Open | Jan 28, 2026 | May 20, 2026 |
| Issue Close | Jan 30, 2026 | May 27, 2026 |
| Basis Of Allotment (Tentative) | Feb 02, 2026 | May 29, 2026 |
| Initiation of Refunds (Tentative) | Feb 03, 2026 | Jun 01, 2026 |
| Credit of Share (Tentative) | Feb 03, 2026 | Jun 01, 2026 |
| Listing date (Tentative) | Feb 04, 2026 | Jun 02, 2026 |
| Anchor Lockin End date 1 | Mar 03, 2026 | |
| Anchor Lockin End date 2 | May 02, 2026 |
Accretion Nutraveda IPO P/E ratio is 26.27, as compared to Harikanta Overseas IPO P/E ratio of 14.66.
| Accretion Nutraveda IPO | Harikanta Overseas IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 96.87 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 70.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.27 | 14.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.40 Cr. | ₹89.78 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 81.22 | 56.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.98 | 37.56 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.72 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.91 | ₹6.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 48.85 | 32.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Nutraveda IPO Retail Individual Investors (RII) are offered 6,40,000 shares while in Harikanta Overseas IPO retail investors are offered 6,40,000 shares. Qualified Institutional Buyers (QIB) are offered 3,64,000 shares in Accretion Nutraveda IPO and 54,000 shares in Harikanta Overseas IPO.
| Accretion Nutraveda IPO | Harikanta Overseas IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,44,000 shares | 0 shares |
| Market Maker Reservation | 96,000 shares | 1,34,400 shares |
| QIB | 3,64,000 shares | 54,000 shares |
| NII | 2,76,000 shares | 12,40,800 shares |
| RII | 6,40,000 shares | 12,40,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 18,24,000 shares | 25,35,600 shares |
Accretion Nutraveda IPO subscribed 1.29x in total, whereas Harikanta Overseas IPO subscribed 1.12x.
| Accretion Nutraveda IPO | Harikanta Overseas IPO | |
|---|---|---|
| QIB (times) | 1.01x | 21.33x |
| NII (times) | 2.08x | 0.70x |
| Big NII (times) | 1.95x | 0.90x |
| Small NII (times) | 2.33x | 0.28x |
| RII (times) | 2.19x | 0.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.29x | 1.12x |
